FI890930A - Menetelmä ihon kautta tapahtuvaa virtausta lisäävän farmaseuttisen valmisteen valmistamiseksi - Google Patents

Menetelmä ihon kautta tapahtuvaa virtausta lisäävän farmaseuttisen valmisteen valmistamiseksi Download PDF

Info

Publication number
FI890930A
FI890930A FI890930A FI890930A FI890930A FI 890930 A FI890930 A FI 890930A FI 890930 A FI890930 A FI 890930A FI 890930 A FI890930 A FI 890930A FI 890930 A FI890930 A FI 890930A
Authority
FI
Finland
Prior art keywords
preparation
human
skin
increases
flow
Prior art date
Application number
FI890930A
Other languages
English (en)
Swedish (sv)
Other versions
FI92650C (fi
FI890930A0 (fi
FI92650B (fi
Inventor
Russell Owen Potts
Michael Lee Francoeur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI890930A0 publication Critical patent/FI890930A0/fi
Publication of FI890930A publication Critical patent/FI890930A/fi
Application granted granted Critical
Publication of FI92650B publication Critical patent/FI92650B/fi
Publication of FI92650C publication Critical patent/FI92650C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI890930A 1988-02-29 1989-02-27 Menetelmä ihon kautta tapahtuvaa virtausta lisäävän farmaseuttisen valmisteen valmistamiseksi FI92650C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16192688A 1988-02-29 1988-02-29
US16192688 1988-02-29

Publications (4)

Publication Number Publication Date
FI890930A0 FI890930A0 (fi) 1989-02-27
FI890930A true FI890930A (fi) 1989-08-30
FI92650B FI92650B (fi) 1994-09-15
FI92650C FI92650C (fi) 1994-12-27

Family

ID=22583397

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890930A FI92650C (fi) 1988-02-29 1989-02-27 Menetelmä ihon kautta tapahtuvaa virtausta lisäävän farmaseuttisen valmisteen valmistamiseksi

Country Status (11)

Country Link
EP (1) EP0331382B1 (fi)
JP (1) JPH0768147B2 (fi)
AT (1) ATE80313T1 (fi)
CA (1) CA1331137C (fi)
DE (1) DE68902753T2 (fi)
DK (1) DK93289A (fi)
ES (1) ES2051998T3 (fi)
FI (1) FI92650C (fi)
GR (1) GR3005657T3 (fi)
IE (1) IE61946B1 (fi)
PT (1) PT89837B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0425443A1 (de) * 1989-10-27 1991-05-02 Ciba-Geigy Ag Injizierbares parasitizides Mittel
US5023085A (en) * 1989-11-29 1991-06-11 Pfizer Inc. Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
DK0453603T3 (da) * 1990-04-26 1993-11-22 Com Pharm Arzneimittel Gmbh Piroxicamholdige farmaceutiske præparater til topisk anvendelse
WO1992017185A1 (en) * 1991-03-29 1992-10-15 University Of Florida Targeted drug delivery via mixed phosphate derivatives
US5496819A (en) * 1991-11-15 1996-03-05 Ss Pharmaceutical Co., Ltd. Antiphlogistic-analgesic plaster comprising triacetin and piroxicam
JP2847578B2 (ja) * 1992-12-31 1999-01-20 スンキョン インダストリイズ カンパニイ リミテッド 皮膚浸透力を高めた医薬組成物
DE4341572C1 (de) * 1993-12-07 1995-06-22 Univ Dresden Tech Zahnriemengetriebe
GB9404248D0 (en) * 1994-03-05 1994-04-20 Boots Co Plc Pharmaceutical formulations
US6106856A (en) * 1994-03-09 2000-08-22 The Board Of Governors For Higher Education, State Of Rhode Island And Providence Plantations Transdermal delivery of calcium channel blockers, such as nifedipine
UA48212C2 (uk) 1996-01-31 2002-08-15 Сергей Дмітрієвіч БУРЛАКОВ Антиглюкокортикоїдний лікарський засіб
CN1252003A (zh) * 1997-03-31 2000-05-03 强生消费者公司 增强药物化合物渗透作用的溶剂系统
BR9814014B1 (pt) 1997-11-10 2014-10-07 Strakan Int Ltd Composição para aplicação tópica tendo propriedades de melhora da penetração
JP4626202B2 (ja) * 2003-07-16 2011-02-02 大正製薬株式会社 ピロキシカム含有外用消炎鎮痛剤組成物
JP2006188500A (ja) * 2004-12-08 2006-07-20 Toyama Chem Co Ltd ピロキシカムを含有する外用液剤
AU2009264307A1 (en) * 2008-06-24 2009-12-30 Intervet International B.V. Pharmaceutical transdermal compositions and method for treating inflammation in cattle
GB0906868D0 (en) * 2009-04-21 2009-06-03 Rabin Bennie Amlodipine salt compositions
CA3102228A1 (en) * 2018-06-01 2019-12-05 Tavanta Therapeutics Hungary Incorporated Topical amlodipine salts for the treatment of anorectal diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2314731A1 (fr) * 1975-06-19 1977-01-14 Nelson Res & Dev Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
JPS60199834A (ja) * 1984-03-23 1985-10-09 Takeda Chem Ind Ltd 経皮吸収外用製剤
JPS59216818A (ja) * 1983-05-26 1984-12-06 Takeda Chem Ind Ltd 経皮吸収外用製剤
US4557934A (en) * 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
MY102980A (en) * 1986-10-31 1993-03-31 Pfizer Transdermal flux enhancing compositions

Also Published As

Publication number Publication date
ATE80313T1 (de) 1992-09-15
IE890642L (en) 1989-08-29
CA1331137C (en) 1994-08-02
IE61946B1 (en) 1994-11-30
EP0331382B1 (en) 1992-09-09
PT89837A (pt) 1989-10-04
PT89837B (pt) 1994-01-31
DK93289A (da) 1989-08-30
FI92650C (fi) 1994-12-27
ES2051998T3 (es) 1994-07-01
DE68902753T2 (de) 1993-01-21
EP0331382A3 (en) 1990-05-30
GR3005657T3 (fi) 1993-06-07
DK93289D0 (da) 1989-02-27
EP0331382A2 (en) 1989-09-06
JPH0768147B2 (ja) 1995-07-26
FI890930A0 (fi) 1989-02-27
FI92650B (fi) 1994-09-15
JPH023613A (ja) 1990-01-09
DE68902753D1 (de) 1992-10-15

Similar Documents

Publication Publication Date Title
MX171058B (es) Composicion farmaceutica que incrementa el flujo transdermico
FI890930A0 (fi) Menetelmä ihon kautta tapahtuvaa virtausta lisäävän farmaseuttisen valmisteen valmistamiseksi
ATE7689T1 (de) 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
JPS5545659A (en) Carcinostatic agent
KR830006178A (ko) 부작용감소와 약효시간이 연장된 새로운 기관지 진정제의 제조방법
ATE41774T1 (de) (+)-cyanidan-3-ol derivate, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung.
JPH04128220A (ja) 抗ヘルペスウイルス剤

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: PFIZER INC.